Regulation & law · 21/11/2002Updated: 10/17/2026 · 1 min read
RMZ Biotech, Inc. to Receive Partially Exclusive Patent License for Dengue Virus Diagnostic Test Kits
Summary
The US Department of the Navy has announced its intention to grant RMZ Biotech, Inc. a non-transferable license to manufacture and distribute Dengue Virus diagnostic test kits worldwide, based on a Government-Owned patent issued in 1999.
Original source language: Federal Register — All DocumentsOpen original release →